2005
Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study
Modi W, Scott K, Goedert J, Vlahov D, Buchbinder S, Detels R, Donfield S, O'Brien S, Winkler C. Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study. Genes & Immunity 2005, 6: 691-698. PMID: 16177829, DOI: 10.1038/sj.gene.6364258.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdolescentAdultAllelesBlack or African AmericanChemokine CXCL12Chemokines, CXCChildCohort StudiesDisease ProgressionFemaleGene FrequencyHaplotypesHIV InfectionsHIV-1HumansLongitudinal StudiesMaleOdds RatioPolymorphism, Single NucleotideRisk FactorsSurvival AnalysisUnited StatesWhite PeopleConceptsSDF-1 geneCohort studySingle nucleotide polymorphismsAfrican AmericansOnly natural ligandSingle disease outcomesX4 HIV-1HIV-1 infectionAIDS Cohort StudyRisk of infectionMACS cohortDisease outcomeHIV-1Epidemiological studiesSDF-1Significant associationChemokine genesInfectionRs1801157Natural ligandProgressionHaplotype analysisCommon haplotypeCXCR4Cohort
1996
Incidence and risk factors for HIV-1 infection—a summary of what is known and the psychiatric relevance
Hoover D, Doherty M, Vlahov D, Miotti P. Incidence and risk factors for HIV-1 infection—a summary of what is known and the psychiatric relevance. International Review Of Psychiatry 1996, 8: 137-148. DOI: 10.3109/09540269609046298.Peer-Reviewed Original ResearchInjection drug useHIV-1 transmissionInfected mothersHuman immunodeficiency virus type 1 (HIV-1) epidemicDrug useSexual HIV-1 transmissionGreatest killerHIV-1 diseaseRisky drug useHIV-1 infectionType 1 epidemicHIV-1 epidemicRisk of infectionRisk of transmissionUse of condomsZidovudine therapyInfected partnerBreast feedingRisk factorsRisk groupsClean needlesHIV-1AIDS casesInfected personsHomosexual men
1991
New Evidence on Intravenous Cocaine Use and the Risk of Infection with Human Immunodeficiency Virus Type 1
Anthony J, Vlahov D, Nelson K, Conn S, Astemborski J, Solomon L. New Evidence on Intravenous Cocaine Use and the Risk of Infection with Human Immunodeficiency Virus Type 1. American Journal Of Epidemiology 1991, 134: 1175-1189. PMID: 1746528, DOI: 10.1093/oxfordjournals.aje.a116021.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBaltimoreBiasCausalityCocaineConfounding Factors, EpidemiologicFemaleHealth BehaviorHIV InfectionsHIV SeroprevalenceHIV-1HumansLogistic ModelsMiddle AgedPredictive Value of TestsPrevalenceProspective StudiesSexual BehaviorSubstance Abuse, IntravenousSurveys and QuestionnairesConceptsIntravenous drug usersDrug treatment programsCocaine injectorsDrug usersHIV seroprevalenceHIV infectionHuman immunodeficiency virus type 1 (HIV-1) infectionTreatment programActive intravenous drug usersHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Preliminary prospective dataIntravenous cocaine useType 1 infectionReceptive anal intercourseMultiple logistic regressionRisk of infectionVirus type 1HIV seroconversionPresent studyExcess riskProspective dataIntravenous usePresent study sample
1989
Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987.
Vlahov D, Brewer F, Muñoz A, Hall D, Taylor E, Polk B. Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1989, 2: 283-90. PMID: 2786071.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus type 1 (HIV-1) infectionHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Incoming male inmatesHIV-1 seroprevalenceIntravenous drug useType 1 infectionImmune deficiency syndromeCause of deathRisk of infectionVirus type 1Drug use variablesWestern blot techniqueCrude prevalenceRisk factorsUnivariate analysisDeficiency syndromeHIV-1Temporal trendsDrug usersDrug useExcess serumIncoming inmates